| Product NDC: | 0409-6780 |
| Proprietary Name: | Lorazepam |
| Non Proprietary Name: | LORAZEPAM |
| Active Ingredient(s): | 2 mg/mL & nbsp; LORAZEPAM |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-6780 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074282 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19940527 |
| Package NDC: | 0409-6780-02 |
| Package Description: | 10 mL in 1 VIAL (0409-6780-02) |
| NDC Code | 0409-6780-02 |
| Proprietary Name | Lorazepam |
| Package Description | 10 mL in 1 VIAL (0409-6780-02) |
| Product NDC | 0409-6780 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LORAZEPAM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19940527 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | LORAZEPAM |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |